A Tradition of Fraud Persists in New Types of Medicare Delivery Models
Unscrupulous medical providers, hospitals, and drug manufacturers, can and do defraud Medicare Advantage plans in the same ways they defraud “traditional” Medicare.
How the Inflation Reduction Act’s Medicare Provisions Will Combat Drug Pricing Fraud
If the IRA’s new Medicare provisions had been in place when the case against Eli Lilly was filed in 2014, many more taxpayer funds may have been recovered.
Fraud By The NumbersFalse Claims ActFraud By The NumbersHealthcare
One Year’s Tax Revenue is Another Year’s Purchases of Drugs and Biologics
Nearly 70 percent of U.S. adults aged 40-79 used at least one prescription drug in 2019. In this blog, we explore the prevalence of fraud in the pharmaceutical industry.
Fraud By The NumbersFalse Claims ActFinancial FraudsFraud By The NumbersHealthcare
Private Equity Investment in Healthcare is Skyrocketing; Grandma Should Be Scared
Between 2010 and 2019, private equity deals in healthcare nearly tripled in value—from $43 billion to $124 billion—totaling $750 billion over the last decade.
Fraud By The NumbersCOVID-19CybersecurityDefenseFalse Claims ActFraud By The NumbersHealthcare
There’s Billions in “Other” Frauds Outside of Healthcare and Defense Contracting
While healthcare and defense spending take up a large portion of the US budget, we're taking a look at the $4 trillion, or 55 percent of "Other" spending.
Fraud By The NumbersCOVID-19False Claims ActFraud By The NumbersHealthcare
Explosion of Telehealth Usage Makes it a Target for Fraudsters
Telehealth usage exploded due to the COVID-19 pandemic, from fewer than 1 million services in 2019 to 52.7 million services. This large user base makes it susceptible to fraud